NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Sebastijan Hobor
Francis Crick Institute - London / United Kingdom
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4472324
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sebastijan Hobor's MOST POPULAR ARTICLES
1-)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerS Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ...Nature 486 (7404), 532-536, 201218302012
2-)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsG Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...Nature medicine 21 (7), 795-801, 20159492015
3-)
Reversible and adaptive resistance to BRAF (V600E) inhibition in melanomaC Sun, L Wang, S Huang, GJJE Heynen, A Prahallad, C Robert, ...Nature 508 (7494), 118-122, 20147792014
4-)
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal CancerA Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ...Cancer discovery 3 (6), 658-673, 20137132013
5-)
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renalS Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ...Cell 173 (3), 595-610. e11, 20185892018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept